NCT00387283View on ClinicalTrials.gov

Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

June 30, 2009

Conditions
West Nile Virus
Interventions
DRUG

AVI-4020 Injection

Trial Locations (1)

98418

NW Kinetics, Tacoma

All Listed Sponsors
lead

Sarepta Therapeutics, Inc.

INDUSTRY

NCT00387283 - Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020 | Biotech Hunter | Biotech Hunter